secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVRx, Inc. (CVRX)
CIK:        0001235912
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0001104659-24-113676
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CMS assigns Barostim to APC 1580; payment ~$45,000 continues in 2025
--------------------------------------------------------------------

- Centers for Medicare and Medicaid Services assigned Barostim procedure to New Technology APC 1580.
- APC payment of approximately $45,000 will continue in 2025 per Medicare OPPS final rule.
- Announcement on November 4, 2024, confirms favorable reimbursement for CVRx's Barostim therapy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1235912/000110465924113676/0001104659-24-113676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1235912/000110465924113676/tm2427376d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-113676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer